An open, multicentre, prospective, non-interventional study of the CE-marked medical device GlucoTab, according to intended use without additional invasive and stressful measures with a matched retrospective control group
Número del projecte / Project number
2023-SUD-2115
Nom i cognoms / Name and surname
Helena Clavero, Joan Duran, Carmen Aguilar i Teresa Auguet
Afiliació / Affiliation
Grup d’Estudi en Malalties Metabòliques Associades a la Insulin-Resistència (GEMMAIR)
Breu explicació del projecte / Brief explanation of your project
This project describes a Digital Diabetes Assistant (GlucoTab) which guides and supports diabetes management. Unlike most other “diabetes apps” and projects, it focuses on supporting healthcare professionals (HCP) and provides insulin dosing advice, driven by validated algorithms and digital processes, allowing for treatment adjustment in seconds instead of days. We aim to develop further, implement, and evaluate the digital diabetes assistant GlucoTab for best-practice care delivery with digitised patient-centred diabetes care in hospitals, domiciliary nursing care and nursing homes in different European pilot regions.
Enllaç a la pàgina web del projecte / Link to your project website
https://www.glucotab.at/en/
Repte en que s’emmarca aquest projecte / Challenge within the framework of this project
–
